Nanostructured Polystyrene Well Plates Allow Unbiased High-Throughput Characterization of Circulating Tumor Cells
Source abstract
Abstract
Rapid, reliable and unbiased circulating tumor cell (CTC) isolation and molecular characterization methods are urgently required for implementation in routine clinical diagnostic and prognostic procedures. We report on the development of a novel unbiased CTC detection approach that combines high-throughput automated microscopy with a simple yet efficient approach for achieving a high level of tumor cell binding in standard tissue culture polystyrene (PS) well plates. A single 5 min high-power oxygen plasma treatment was used to create homogeneous nanoscale roughness on standard PS tissue culture plates and, in turn, drastically enhance the binding of a range of tumor cells. After physical adsorption of an adlayer of poly-l-lysine, binding yields above 97% were obtained at 2 h for all tumor cell lines used in the study. Morphological analysis of the cells confirmed strong adherence to the nanorough PS substrates. Clinically relevant concentrations of a highly metastatic breast cancer cell line, used as model for CTCs, could be reliably detected among blood cells on the nanorough polystyrene plates using an automated microscopy system. The approach was then successfully used to detect CTCs in the blood of a stage IIIc colorectal cancer patient. By combining the high binding abilities of nanorough PS well plates with the high-throughput nature of high-content analysis systems, this methodology has great potential toward enabling unbiased routine clinical analysis of CTCs. It could be applied, once clinically validated, in any clinical center equipped with an automated microscopy facility at a fraction of the cost of current CTC isolation technologies.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cancer Cells and Metastasis · Microfluidic and Bio-sensing Technologies · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Ian Wark Research Institute, University of South Australia, Mawson Lakes, Adelaide, South Australia 5095, Australia
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Mawson Institute, University of South Australia, Mawson Lakes, Adelaide, South Australia 5095, Australia
The Queen Elizabeth Hospital and University of Adelaide, Adelaide, South Australia 5011 Australia
School of Medical Sciences, University of Adelaide, Adelaide, South Australia 5095, Australia
Funding
National Health and Medical Research Council
References (37)
Show source-provided references
1. Alix-Panabieres C. · Clin. Chem. · 2013 · 59 · 11010.1373/clinchem.2012.194258 ↗
2. Kang Y. · Cancer Cell · 2013 · 23 · 57310.1016/j.ccr.2013.04.017 ↗
3. van de Stolpe A. · Cancer Res. · 2011 · 71 · 595510.1158/0008-5472.CAN-11-1254 ↗
4. Zhang L. · Clin. Cancer Res. · 2012 · 18 · 570110.1158/1078-0432.CCR-12-1587 ↗
5. Gorges T. M. · Cancer Immunol. Immunother. · 2013 · 62 · 93110.1007/s00262-012-1387-1 ↗
6. Joosse S. A. · Cancer Res. · 2013 · 73 · 810.1158/0008-5472.CAN-12-3422 ↗
7. Yu M. · Nature · 2012 · 487 · 51010.1038/nature11217 ↗
8. Yu M. · Science · 2013 · 339 · 58010.1126/science.1228522 ↗
9. Yu M. · J. Cell Biol. · 2011 · 192 · 37310.1083/jcb.201010021 ↗
10. Jin C. · Lab Chip · 2014 · 14 · 3210.1039/C3LC50625H ↗
11. Hardingham J. E. · Cancer Res. · 1993 · 53 · 3455
12. Nagrath S. · Nature · 2007 · 450 · 123510.1038/nature06385 ↗
13. Grover P. · Ann. Oncol. · 2014 · 25 · 150610.1093/annonc/mdu018 ↗
14. Joosse S. A. · Clin. Cancer Res. · 2012 · 18 · 99310.1158/1078-0432.CCR-11-2100 ↗
15. Mikolajczyk S. D. · J. Oncol. · 2011 · 2011 · 25236110.1155/2011/252361 ↗
16. Zheng Q. · Biotechnol. Adv. · 2013 · 31 · 166410.1016/j.biotechadv.2013.08.013 ↗
17. Harouaka R. A. · J. Lab. Autom. · 2013 · 18 · 45510.1177/2211068213494391 ↗
18. Guo Q. · Lab Chip · 2012 · 12 · 268710.1039/c2lc40205j ↗
19. Zhang W. · Proc. Natl. Acad. Sci. U.S.A. · 2012 · 109 · 1870710.1073/pnas.1209893109 ↗
20. Hofman V. J. · Am. J. Clin. Pathol. · 2011 · 135 · 14610.1309/AJCP9X8OZBEIQVVI ↗
21. Asghar W. · Lab Chip · 2012 · 12 · 234510.1039/c2lc21012f ↗
22. Lim L. S. · Lab Chip · 2012 · 12 · 438810.1039/c2lc20750h ↗
23. Marrinucci D. · Phys. Biol. · 2012 · 9 · 01600310.1088/1478-3975/9/1/016003 ↗
24. Wang L. X. · Nano Today · 2013 · 8 · 37410.1016/j.nantod.2013.07.001 ↗
25. Chen W. Q. · ACS Nano · 2013 · 7 · 56610.1021/nn304719q ↗
26. Fischer J. C. · Proc. Natl. Acad. Sci. U.S.A. · 2013 · 110 · 1658010.1073/pnas.1313594110 ↗
27. Zeiger A. S. · Acta Biomater · 2013 · 9 · 735410.1016/j.actbio.2013.02.035 ↗
28. Ishizaki T. · Langmuir · 2010 · 26 · 814710.1021/la904447c ↗
29. Wan Y. · Cancer Res. · 2010 · 70 · 937110.1158/0008-5472.CAN-10-0568 ↗
30. Wan Y. · Cancer · 2012 · 118 · 114510.1002/cncr.26349 ↗
31. Keddie J. L. · Europhys. Lett. · 1994 · 27 · 5910.1209/0295-5075/27/1/011 ↗
32. Wong C. W. · Cancer Res. · 2001 · 61 · 333
33. Ko T. J. · Soft Matter · 2013 · 9 · 870510.1039/c3sm51147b ↗
34. Liu X. · NPG Asia Mater. · 2013 · 5 · e6310.1038/am.2013.43 ↗
35. Hallab N. · J. Long-Term Eff. Med. Implants · 1994 · 5 · 209
36. Chang X. Z. · Breast Cancer Res. Treat. · 2008 · 111 · 6510.1007/s10549-007-9761-y ↗
37. Williams A. · Clin. Cancer Res. · 2011 · 17 · 305010.1158/1078-0432.CCR-11-0512 ↗